CD274 and malignant colon neoplasm: A tumor-specific targeted synergistic strategy was designed by coupling anti-PD-L1 polypeptide with chemotherapy for colon cancer, where a proteolysis resistant PD-L1-targeted peptide PPA1 was conjugated to DOX with a pH sensitive linker (Figure 1A).